How many institutions held GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value in Q1 2016?

32 institutional investors reported GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value for Q1 2016. Use the holders table for investor-level position and value details.

Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG)

Q: What does CUSIP 36315X101 represent in this 13F holders report?

CUSIP 36315X101 is the security identifier for GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value used to aggregate holder disclosures.

CUSIP: 36315X101

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Ordinary shares, no par value
Shares outstanding: 66,186,595
Total 13F shares: 8,766,614
Share change: +529,124
Total reported value: $366,590,000
Price per share: $41.82
Number of holders: 32
Value change: +$15,263,420
Number of buys: 17
Number of sells: 26

Quarterly Holders Quick Answers

What is CUSIP 36315X101?
CUSIP 36315X101 identifies GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2016
Previous quarter: Q4 2015

Recent filing periods for CUSIP 36315X101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	5.9%	3,907,634	$245,712,000	—	31 Dec 2015	13F
FEDERATED HERMES, INC.	13F	Company	1.7%	1,102,773	$69,342,000	—	31 Dec 2015	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.94%	622,543	$39,145,000	—	31 Dec 2015	13F
BAKER BROS. ADVISORS LP	13F	Company	0.56%	369,276	$23,220,000	—	31 Dec 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.56%	369,086	$23,208,000	—	31 Dec 2015	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.45%	300,000	$18,864,000	—	31 Dec 2015	13F
ORBIMED ADVISORS LLC	13F	Company	0.35%	230,000	$14,462,000	—	31 Dec 2015	13F
Rock Springs Capital Management LP	13F	Company	0.32%	210,000	$13,205,000	—	31 Dec 2015	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.28%	183,000	$11,507,000	—	31 Dec 2015	13F
EcoR1 Capital, LLC	13F	Company	0.25%	167,361	$10,524,000	—	31 Dec 2015	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.19%	125,800	$7,910,000	—	31 Dec 2015	13F
MORGAN STANLEY	13F	Company	0.17%	112,640	$7,083,000	—	31 Dec 2015	13F
GLG Partners LP	13F	Company	0.11%	70,309	$4,421,000	—	31 Dec 2015	13F
Point72 Asset Management, L.P.	13F	Company	0.1%	63,600	$3,999,000	—	31 Dec 2015	13F
ALPS ADVISORS INC	13F	Company	0.08%	51,393	$3,232,000	—	31 Dec 2015	13F
EverPoint Asset Management, LLC	13F	Company	0.08%	49,981	$3,143,000	—	31 Dec 2015	13F
Atika Capital Management LLC	13F	Company	0.06%	42,000	$2,641,000	—	31 Dec 2015	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	37,900	$2,383,000	—	31 Dec 2015	13F
MACQUARIE GROUP LTD	13F	Company	0.05%	34,533	$2,171,000	—	31 Dec 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.05%	31,101	$1,953,000	—	31 Dec 2015	13F
DAFNA Capital Management LLC	13F	Company	0.05%	30,000	$1,886,000	—	31 Dec 2015	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.04%	26,890	$1,691,000	—	31 Dec 2015	13F
Tekla Capital Management LLC	13F	Company	0.03%	20,000	$1,258,000	—	31 Dec 2015	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.02%	14,500	$912,000	—	31 Dec 2015	13F
Rail-Splitter Capital Management, LLC	13F	Company	0.02%	12,849	$808,000	—	31 Dec 2015	13F
E. E. Geduld	13F	Individual	0.02%	11,000	$692,000	—	31 Dec 2015	13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.01%	8,101	$509,000	—	31 Dec 2015	13F
Airain ltd	13F	Company	0.01%	7,541	$474,000	—	31 Dec 2015	13F
UBS Group AG	13F	Company	0.01%	4,456	$280,000	—	31 Dec 2015	13F
Cubist Systematic Strategies, LLC	13F	Company	0.01%	3,946	$248,000	—	31 Dec 2015	13F
Cavalier Investments, LLC	13F	Company	0.01%	3,400	$214,000	—	31 Dec 2015	13F
NAVELLIER & ASSOCIATES INC	13F	Company	0.01%	3,400	$214,000	—	31 Dec 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	3,353	$210,000	—	31 Dec 2015	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0%	3,000	$189,000	—	31 Dec 2015	13F
Creative Planning	13F	Company	0%	1,400	$88,000	—	31 Dec 2015	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	659	$41,000	—	31 Dec 2015	13F
BlackRock Finance, Inc.	13F	Company	0%	500	$31,000	—	31 Dec 2015	13F
ROYAL BANK OF CANADA	13F	Company	0%	420	$26,000	—	31 Dec 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	250	$16,000	—	31 Dec 2015	13F
Edge Wealth Management LLC	13F	Company	0%	200	$13,000	—	31 Dec 2015	13F
Walleye Trading LLC	13F	Company	0%	200	$13,000	—	31 Dec 2015	13F
CITIGROUP INC	13F	Company	0%	49	$3,000	—	31 Dec 2015	13F
US BANCORP \DE\	13F	Company	0%	46	$3,000	—	31 Dec 2015	13F

Institutional Holders of Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) as of Q1 2016

As of 31 Mar 2016, Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,766,614 shares. The largest 10 holders included FMR LLC, FEDERATED INVESTORS INC /PA/, WELLINGTON MANAGEMENT GROUP LLP, GOLDMAN SACHS GROUP INC, DEERFIELD MANAGEMENT CO, BAKER BROS. ADVISORS LP, EcoR1 Capital, LLC, ORBIMED ADVISORS LLC, Rock Springs Capital Management LP, and ADAGE CAPITAL PARTNERS GP, L.L.C.. This page lists 32 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q4 2015 Across Filers

Q4 2015 holders

Q1 2016 holders

Holder diff

-11

Investor	Q4 2015 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q4 2015 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.